Peter C Harris Selected Research

polycystic kidney disease 1 protein

11/2019	Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.
4/2009	Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.
2/2009	Characterization of PKD protein-positive exosome-like vesicles.
3/2004	A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter C Harris Research Topics

Disease

79	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 05/2002
37	Cysts 03/2022 - 11/2003
26	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2022 - 11/2003
16	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 11/2019 - 03/2002
12	Disease Progression 01/2022 - 03/2007
9	Chronic Kidney Failure (Chronic Renal Failure) 04/2021 - 05/2002
8	Fibrosis (Cirrhosis) 01/2022 - 11/2003
8	Liver Diseases (Liver Disease) 01/2020 - 11/2004
8	Polycystic liver disease 01/2020 - 03/2007
6	Primary Hyperoxaluria (Oxaluria, Primary) 01/2022 - 06/2007
6	Cystic Kidney Diseases (Cystic Kidney Disease) 01/2022 - 01/2008
6	Ciliopathies 01/2022 - 09/2009
5	Hypercalciuria 03/2022 - 03/2012
5	Chronic Renal Insufficiency 07/2021 - 12/2014
4	Nephrolithiasis 07/2021 - 04/2010
4	Body Weight (Weight, Body) 01/2021 - 11/2003
3	Nephrocalcinosis 03/2022 - 02/2019
3	Inflammation (Inflammations) 01/2022 - 08/2015
3	Meckel syndrome type 1 05/2013 - 02/2006
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 07/2021
2	Hypercalcemia (Milk Alkali Syndrome) 07/2021 - 03/2012
2	Hypertension (High Blood Pressure) 12/2018 - 08/2003
2	Hypotension (Low Blood Pressure) 01/2018 - 12/2014
2	Proteinuria 12/2016 - 01/2016
2	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2015 - 06/2011
2	Pain (Aches) 12/2014 - 06/2010
1	Urinary Calculi (Urinary Calculus) 03/2022
1	Hypophosphatemia 03/2022
1	Calculi (Calculus) 01/2022
1	Polyuria 01/2022
1	Hyperoxaluria (Oxaluria) 01/2022
1	Water Intoxication 01/2022
1	Pyuria 01/2022
1	Kidney Calculi (Kidney Stone) 01/2022
1	Albuminuria 01/2022

Drug/Important Bio-Agent (IBA)

37	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2002
11	CalciumIBA 01/2022 - 01/2006
10	TRPP Cation ChannelsIBA 01/2020 - 06/2002
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
6	CreatinineIBA 04/2021 - 08/2010
6	1-dodecylpyridoxal (PLD)IBA 06/2019 - 06/2010
6	Tolvaptan FDA Link 10/2018 - 04/2005
5	Pharmaceutical PreparationsIBA 11/2021 - 11/2016
4	Vitamin D3 24-HydroxylaseIBA 03/2022 - 03/2012
4	polycystic kidney disease 1 proteinIBA 11/2019 - 03/2004
4	Epidermal Growth Factor (EGF)IBA 01/2017 - 11/2003
4	Vasopressins (Vasopressin)IBA 08/2015 - 03/2007
4	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 06/2003
3	OxalatesIBA 01/2022 - 10/2015
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2016
3	polycystic kidney disease 2 proteinIBA 11/2019 - 03/2004
3	Sirolimus (Rapamycin)FDA Link 12/2018 - 01/2016
3	Peptides (Polypeptides)IBA 01/2017 - 03/2007
3	NucleotidesIBA 11/2016 - 05/2002
3	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 02/2015 - 04/2005
2	Vitamin D FDA LinkGeneric 03/2022 - 07/2021
2	1,25-dihydroxyvitamin DIBA 03/2022 - 03/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 11/2006
2	Calcitriol (Calcijex)FDA LinkGeneric 07/2021 - 03/2012
2	EnzymesIBA 07/2021 - 01/2017
2	LipidsIBA 01/2021 - 11/2016
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2020 - 01/2003
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 03/2007
2	pasireotideIBA 01/2020 - 01/2015
2	SaltsIBA 11/2019 - 06/2009
2	Iothalamic Acid (Iotalamic Acid)FDA Link 12/2018 - 05/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 02/2013
2	TEMPOIBA 01/2018 - 11/2016
2	MTOR InhibitorsIBA 01/2018 - 06/2015
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2017 - 01/2016
2	adenylyl cyclase 6IBA 01/2017 - 01/2015
2	Amino Acids FDA Link 11/2016 - 10/2003
2	diethylstilbestrol monophosphate (PDES)IBA 01/2016 - 01/2010
2	Nonsense Codon (Nonsense Mutation)IBA 03/2015 - 02/2014
2	Adenosine Monophosphate (AMP)IBA 01/2015 - 01/2010
2	Lisinopril (Prinivil)FDA LinkGeneric 12/2014 - 12/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2014 - 12/2014
2	AlbuminsIBA 12/2014 - 12/2014
2	Telmisartan (Micardis)FDA Link 12/2014 - 12/2014
2	Proprotein Convertase 2IBA 10/2013 - 08/2003
2	beta CateninIBA 09/2010 - 03/2004
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2010 - 03/2007
2	Octreotide (Sandostatin)FDA LinkGeneric 06/2010 - 03/2007
2	Adenosine (Adenocard)FDA LinkGeneric 03/2007 - 11/2004
2	Cyclic AMP (AMP, Cyclic)IBA 01/2006 - 04/2004
2	ErbB Receptors (EGF Receptor)IBA 11/2004 - 11/2003
2	Transforming Growth Factor alpha (TGF-alpha)IBA 11/2004 - 11/2003
2	EKB 569IBA 11/2004 - 11/2003
2	CL 387785IBA 11/2004 - 11/2003
2	Urea (Carbamide)FDA LinkGeneric 04/2004 - 11/2003
2	NitrogenIBA 04/2004 - 11/2003
1	Phosphates (Orthophosphate)IBA 03/2022
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2022
1	GlutaratesIBA 01/2022
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Citric Acid (Citrate)FDA LinkGeneric 01/2022

Therapy/Procedure

15	Therapeutics 01/2020 - 11/2004
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 12/2011